Ignite Creation Date:
2024-05-05 @ 5:16 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00425854
Status:
COMPLETED
Last Update Posted:
2013-12-31
First Post:
2007-01-22
Brief Title:
An Open Label Phase II Trial of BIBW 2992 in Patients With HER2-negative Metastatic Breast Cancer
Sponsor:
Organization:
Boehringer Ingelheim